| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma
|
Im, Jung Ho
|
|
|
147 |
8 |
p. 2435-2445
|
article
|
| 2 |
Angiogenesis and chemotherapy resistance: optimizing chemotherapy scheduling using mathematical modeling
|
Bodzioch, Mariusz
|
|
|
147 |
8 |
p. 2281-2299
|
article
|
| 3 |
A novel NECTIN4-NTRK1 fusion identified in a lung squamous cell carcinoma patient with MSI-H
|
Li, Peng
|
|
|
147 |
8 |
p. 2483-2486
|
article
|
| 4 |
Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer
|
Zhang, Yu
|
|
|
147 |
8 |
p. 2209-2222
|
article
|
| 5 |
Associated factors and outcomes of delaying adjuvant chemotherapy in breast cancer by biologic subtypes: a National Cancer Database study
|
Ashok Kumar, Prashanth
|
|
|
147 |
8 |
p. 2447-2458
|
article
|
| 6 |
Aurora B kinase: a potential drug target for cancer therapy
|
Ahmed, Azaj
|
|
|
147 |
8 |
p. 2187-2198
|
article
|
| 7 |
A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy
|
Steidl, Eike
|
|
|
147 |
8 |
p. 2373-2383
|
article
|
| 8 |
Comparative evaluation of cardiovascular risks among nine FDA-approved VEGFR-TKIs in patients with solid tumors: a Bayesian network analysis of randomized controlled trials
|
Hou, Wanting
|
|
|
147 |
8 |
p. 2407-2420
|
article
|
| 9 |
Correction to: Multigene panel testing for hereditary breast and ovarian cancer in the province of Ontario
|
Lerner-Ellis, Jordan
|
|
|
147 |
8 |
p. 2487
|
article
|
| 10 |
Detection of circulating genetically abnormal cells using 4-color fluorescence in situ hybridization for the early detection of lung cancer
|
Feng, Mingxiang
|
|
|
147 |
8 |
p. 2397-2405
|
article
|
| 11 |
Effects of a patient-tailored integrative oncology intervention in the relief of pain in palliative and supportive cancer care
|
Ben-Arye, Eran
|
|
|
147 |
8 |
p. 2361-2372
|
article
|
| 12 |
EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience
|
Ianza, Anna
|
|
|
147 |
8 |
p. 2301-2307
|
article
|
| 13 |
Exploring polyps to colon carcinoma voyage: can blocking the crossroad halt the sequence?
|
Khan, Abdul Arif
|
|
|
147 |
8 |
p. 2199-2207
|
article
|
| 14 |
Expression of ISL1 and its partners in prostate cancer progression and neuroendocrine differentiation
|
Alshalalfa, Mohammed
|
|
|
147 |
8 |
p. 2223-2231
|
article
|
| 15 |
High nuclear expression of HIF1α, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence
|
Basu, Mukta
|
|
|
147 |
8 |
p. 2309-2322
|
article
|
| 16 |
Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade glioma
|
Hölzl, Dorothee
|
|
|
147 |
8 |
p. 2271-2280
|
article
|
| 17 |
Is the prediction of one or two ipsilateral positive lymph nodes by computerized tomography and ultrasound reliable enough to restrict therapeutic neck dissection in oral squamous cell carcinoma (OSCC) patients?
|
Sproll, Karl Christoph
|
|
|
147 |
8 |
p. 2421-2433
|
article
|
| 18 |
Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review
|
Raj, Rishi
|
|
|
147 |
8 |
p. 2337-2347
|
article
|
| 19 |
Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV)
|
Holzhey, Tanja
|
|
|
147 |
8 |
p. 2349-2359
|
article
|
| 20 |
Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05
|
Park, Ji Hyun
|
|
|
147 |
8 |
p. 2459-2469
|
article
|
| 21 |
Role of lung and gut microbiota on lung cancer pathogenesis
|
Zhao, Yue
|
|
|
147 |
8 |
p. 2177-2186
|
article
|
| 22 |
Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer
|
Rachner, Tilman D.
|
|
|
147 |
8 |
p. 2233-2238
|
article
|
| 23 |
Survival benefit of conversion surgery after intensive chemotherapy for unresectable metastatic gastric cancer: a propensity score-matching analysis
|
Ohnuma, Hiroyuki
|
|
|
147 |
8 |
p. 2385-2396
|
article
|
| 24 |
Testicular cancer follow-up costs in Germany from 2000 to 2015
|
Michaeli, Thomas
|
|
|
147 |
8 |
p. 2249-2258
|
article
|
| 25 |
The ability of post-chemoradiotherapy DWI ADCmean and 18F-FDG SUVmax to predict treatment outcomes in head and neck cancer: impact of human papilloma virus oropharyngeal cancer status
|
Connor, S.
|
|
|
147 |
8 |
p. 2323-2336
|
article
|
| 26 |
The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients
|
Xie, Jiebin
|
|
|
147 |
8 |
p. 2259-2269
|
article
|
| 27 |
The status of WIF1 methylation in cell-free DNA is associated with the insusceptibility for gefitinib in the treatment of lung cancer
|
Shen, Zhijun
|
|
|
147 |
8 |
p. 2239-2248
|
article
|
| 28 |
Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunities
|
Wehling, Cyrill
|
|
|
147 |
8 |
p. 2471-2481
|
article
|
Journal description